Showing 18,781 - 18,800 results of 30,492 for search '(( 2 step decrease ) OR ( 50 ((((teer decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.05s Refine Results
  1. 18781
  2. 18782

    Sensitivity analysis. by Daniela S Santurio (21030812)

    Published 2025
    “…For each patient, a constant 50% reduction in each activation mechanism was simulated and the mean reduction in IL6 peak was calculated (reference scenario, black dots, same values as shown in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012908#pcbi.1012908.g008" target="_blank">Fig 8A</a> fourth panel); this analysis was then repeated by increasing ( + ) and decreasing (–) each parameter in 50% increments.…”
  3. 18783
  4. 18784

    Supplementary Figures S1-S11 from The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer by Fang Fang (38179)

    Published 2023
    “…Comparison of cell growth rates of parental A2780 cells (A), A2780-CDDP resistant cells (B), and CP70 CDDP resistant cells (C) treated with 5μM 5-aza-dC, or vehicle (DMSO 1:2000) for 48 hours followed by CDDP ranging from 0-50μM CDDP. …”
  5. 18785

    DataSheet1_Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder.docx by Chaoli Chen (20359785)

    Published 2024
    “…Background<p>In the treatment of depression, medication plays a crucial role. However, insufficient patient adherence to medication often results in unsatisfactory treatment outcomes, increasing both the recurrence and rehospitalization rates of depression, and consequently imposing a greater economic burden on the healthcare system.…”
  6. 18786

    Coarse-grained model leads to collective behavior. by Giovanna De Palo (476510)

    Published 2017
    “…The peak in susceptibility becomes higher the larger the number of cells, and NN distances decrease accordingly. Profiles in the inset were smoothed with a moving average filter spanning ten points. …”
  7. 18787
  8. 18788
  9. 18789
  10. 18790
  11. 18791
  12. 18792
  13. 18793
  14. 18794
  15. 18795
  16. 18796
  17. 18797

    Data_Sheet_1_SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway.doc by Xiao-Ning Li (2008540)

    Published 2020
    “…In this study, we show that SWL-1 reverses resistance to fluconazole in C. albicans when delivered in combination, with a sharp decrease in the IC<sub>50</sub> of fluconazole from >200 to 3.74 ± 0.25 μg/ml, and also reverses the fluconazole resistance of C. albicans in vitro, with IC<sub>50</sub> from >200 to 5.3 ± 0.3 μg/ml. …”
  18. 18798

    An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers by Moran Elishmereni (203218)

    Published 2011
    “…Simulations of the verified model surfaced important therapeutic insights: (1) Fractionating the standard daily regimen (50 µg/dose) into a twice daily schedule (25 µg/dose) is advantageous, yielding a significantly lower tumor mass (45% decrease); (2) A low-dose (12 µg/day) regimen exerts a response similar to that obtained under the 50 µg/day treatment, suggestive of an equally efficacious dose with potentially reduced toxicity. …”
  19. 18799
  20. 18800